Table 3 Follow-up results: Clinical outcomes.

From: Adherence to guideline recommendations for coronary angiography in a poor South-East Asian setting: Impact on short- and medium-term clinical outcomes

Clinial outcomes

Adhere

Not adhere

(n = 201)

Total

(n = 474)

p-value

With Revascularization

(n = 113)

No Revascularization

(n = 160)

≤30 days

CVD death

3 (2.7)

11 (6.9)

48 (23.9)

62 (13.1)

<0.001

CVD re-hospitalization*

9 (8.0)

17 (10.6)

4 (2.0)

30 (6.3)

0.003

First PCI/CABG

24 (21.2)

N/A

N/A

24 (5.1)

N/A

Repeated PCI/CABG

5 (4.4)

N/A

N/A

5 (1.1)

N/A

>30 days up to the end of follow-up

CVD death

13 (11.5)

33 (20.6)

45 (22.4)

91 (19.2)

0.054

Non-CVD death

0 (0.0)

1 (0.6)

1 (0.5)

2 (0.4)

0.718

CVD re-hospitalization*

21 (18.6)

20 (12.5)

16 (8.0)

57 (12.0)

0.021

Non-CVD hospitalization

2 (1.8)

0 (0.0)

0 (0.0)

2 (0.4)

0.040

First PCI/CABG†

14 (12.4)

5 (3.1)

4 (2.0)

23 (4.9)

<0.001

Repeated PCI/CABG†

9 (8.0)

N/A

N/A

9 (1.9)

N/A

At 30-day follow-up‡

(n = 110)

(n = 149)

(n = 153)

(n = 412)

 

Adherence to post-discharge medication

76 (69.1)

61 (40.9)

42 (27.5)

179 (43.4)

<0.001

  1. Values are n (%). Differences were estimated using Pearson’s or exact Chi-square test.
  2. *Defined as re-hospitalization due to myocardial infarction, heart failure, stroke, and stent thrombosis.
  3. †Measured at ≥ 6 months after discharge.
  4. ‡Measured only for survivors.
  5. CVD = cardiovascular disease; PCI = percutaneous coronary intervention; CABG = coronary artery bypass grafting.
Back to article page